September 5, 2013
London, Dec 2-4
Translating Oncology Drug Discovery into Improved Patient Outcomes using Human Surrogate Trials (HuTrials®)
- Identify biomarker signatures of patient responders and non-responders
- Reduce the attrition rate of NCEs in the clinic
- Accelerate drug development and improve your chances of success
Rajendra Kumari, CSO & Founder, PRECOS Ltd (A Crown Bioscience Company)
Join us at the event to hear about our latest research.